Product Images Lansoprazole

This is a description of a medication called Lansoprazole, which is contained in delayed-release capsules. The medication is produced by GSMS Incorporated and packaged in the United States. Each capsule contains 30mg of Lansoprazole. Customers are instructed to follow the usage details in the package insert and to store the medication at a controlled room temperature. Additionally, pharmacists are instructed to provide a Medication Guide to each patient alongside the drug.*

This is a chart showing the mean severity of day heartburn by study day for evaluable patients. There are three groups being compared: placebo, Lansoprazole 15 mg QD, and Lansoprazole 30 mg QD. The severity is measured on a scale of 0 (none) to 3 (severe). The chart shows the data for study days 18, 20, and 25.*

This text represents a table showing the mean severity of night heartburn by study day for evaluable patients who received different treatments. The severity of heartburn was measured using a scale where 3 indicates severe heartburn, 2 indicates moderate heartburn, 1 is unclear, and 0 indicates no heartburn. The table includes data for three treatment groups consisting of a placebo, lansoprazole 15 mg QD, and lansoprazole 30 mg QD. The table reports data for 18 days from the start of the treatment, and it shows the percentage of patients who experience heartburn of different severity levels on different days.*